CD19 and acute lymphoblastic leukemia: When tested against the KMT2A::AFF1 CD19+CD133+ B-ALL cell line SEM, bispecific CAR-iNKT cells were more cytotoxic than their monospecific counterparts in 4-hour and 24-hour cytotoxicity assays (Figure 1C).